Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients. - Wikidata - wikimedia - TriplyDB

Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients.

Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients.

http://www.wikidata.org/entity/Q44801909

about

Diagnosis and treatment of invasive fungal infections in the cancer patient: recent progress and ongoing questions Delaying diagnostic procedure significantly increases mortality in patients with invasive mucormycosis.Molecular and nonmolecular diagnostic methods for invasive fungal infections.Rapid detection and identification of mucormycetes in bronchoalveolar lavage samples from immunocompromised patients with pulmonary infiltrates by use of high-resolution melt analysis Utility of real-time PCR for detection of Exserohilum rostratum in body and tissue fluids during the multistate outbreak of fungal meningitis and other infections Laboratory diagnosis of mucormycosis: current status and future perspectives.Development of new strategies for early diagnosis of mucormycosis from bench to bedside.Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections Prevalence of the reversed halo sign in neutropenic patients compared with non-neutropenic patients: Data from a single-centre study involving 27 patients with pulmonary mucormycosis (2003-2016).CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Is It Time to Include CT "Reverse Halo Sign" and qPCR Targeting Mucorales in Serum to EORTC-MSG Criteria for the Diagnosis of Pulmonary Mucormycosis in Leukemia Patients?Epidemiology and treatment of mucormycosis.Invasive fungal infections in the ICU: how to approach, how to treat.Update on fungal diagnostics.New fungal diagnostics.Non-cultural methods for the diagnosis of invasive fungal disease.Fatal Pulmonary Mucormycosis due to Rhizopus homothallicus.Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA-microarray from primary clinical samples.Nucleic acid amplification methodologies for the detection of pulmonary mold infections.Invasive mould infections in the ICU setting: complexities and solutions.Future Research Priorities in Fungal Resistance.Management of Pulmonary Mucormycosis Based on a Polymerase Chain Reaction (PCR) Diagnosis in Patients with Hematologic Malignancies: A Report of Four Cases.Detection of Circulating Mucorales DNA in Critically Ill Burn Patients: Preliminary Report of a Screening Strategy for Early Diagnosis and Treatment.Detection of mucormycetes and other pathogenic fungi in formalin fixed paraffin embedded and fresh tissues using the extended region of 28S rDNA.Evolution of procalcitonin, C-reactive protein and fibrinogen levels in neutropenic leukaemia patients with invasive pulmonary aspergillosis or mucormycosis.Green herring syndrome: bacterial infection in patients with mucormycosis cavitary lung disease Comparison of serum PCR assay and histopathology for the diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients with sinus involvement.Role of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children.Rare fungal infectious agents: a lurking enemy.Tumor shape pulmonary mucormycosis associated with sinonasal aspergillosis in a diabetic patient.Determining the analytical specificity of PCR-based assays for the diagnosis of IA: What is Aspergillus?Editorial Commentary: Toward New Tools to Assess Rare Invasive Fungal Diseases in Critically Ill Patients.Early detection of Rhizopus DNA in the serum of a patient with rhino-orbital-cerebral mucormycosis following allogeneic hematopoietic stem cell transplantation.Diagnostic Modalities for Invasive Mould Infections among Hematopoietic Stem Cell Transplant and Solid Organ Recipients: Performance Characteristics and Practical Roles in the Clinic.Cutaneous mucormycosis.Breakthrough invasive aspergillosis and diagnostic accuracy of serum galactomannan enzyme immune assay during acute myeloid leukemia induction chemotherapy with posaconazole prophylaxis.Primary Oral Mucormycosis Due to Rhizopus microsporus after Allogeneic Stem Cell Transplantation

P2860

Q27015890-B713125D-C40F-4BD9-B769-F8238347DFC2 Q33427532-530C7032-686C-40AD-ACD5-B5067E9031B8 Q34057660-169CA5DE-7AFF-4DA7-BC3F-19ED2DD37B6B Q34058831-221B696D-83EC-4F53-9B76-D05A9FC45237 Q34983147-24C405EF-E8BE-417B-A569-C9B269BF8373 Q35193540-6CFF3550-56FA-4BBB-9D72-DB00972565AC Q35491540-1C654A21-A4E8-469C-BCEF-DF1FAF3E6C8B Q36125981-1E88741F-7243-46F0-9243-24C068E136E1 Q36353240-A1FF1866-A054-4A2E-802E-7A2321DEF8D1 Q37041199-A71F5AE6-B074-43EF-95E2-A7532A3E32E6 Q37579527-CB966E40-BE37-4FBB-9AE6-6BDA8A91E3B5 Q38135904-0B4DC0E1-FA6F-4209-8324-F2ECC6B6CA8D Q38180287-7AC8868E-6EFA-4DD1-80C1-043FA5417A53 Q38217351-2987D3C3-6BE0-4128-88C7-D8D3CD848F6F Q38231463-5329360E-A51C-4C18-8749-A650C0ECB8BC Q38266817-809E10C2-5B0E-4532-8B9B-B35A5E7A948E Q38744413-EF36C0C5-0501-4E4D-BA3C-F4F21CC9FBA8 Q38912624-D146CEC0-9C4D-43F7-A38F-3829AF37F17E Q39144117-484554CB-3C79-4A84-A36F-6EEEB55372BA Q39206915-F51EA7C5-BAF5-4344-87E6-76969D79A53C Q40045680-C32AC5A5-B288-4DEE-BCEB-DC5E49D9B464 Q40287118-0953B65F-A193-4654-91CD-791655BBBC89 Q40480725-076C310A-DB63-4AA7-BC8B-DA888E6E62F9 Q40539767-91A631AC-7641-4DB9-BF1A-3BDDEC990F56 Q40771604-79D096BA-B676-4089-8EDE-6DD36F73BDAF Q41454029-856FFD3E-4660-478E-8DD7-F2B1D222E968 Q41671639-9676FC9B-E919-417A-8528-E8348FF2C739 Q41996456-C42664C4-6975-49AD-AEA8-56F8BF61A6C6 Q46258749-366564F2-4BF6-4A47-995A-FCB12E8308FD Q46362200-ED7F97F2-6239-432D-AA30-300875E2230B Q46616809-FF7CEC9F-B8CC-4CF3-936B-30D29132247C Q47372048-D40C86FF-2CB5-4F89-BF1D-E575DCDFB31F Q48968404-15DABF4A-B45E-42E5-94F1-FC0E6775E79B Q49307735-56303291-2860-4DF8-9254-D8B13ACCD073 Q49510166-3A3B3806-8984-4FC2-8822-5BB4F3D0FDD8 Q55386407-A1DF93DE-9783-47A0-B83C-13180CEBFBCF Q58772822-2A594402-4146-4C6D-9C99-83AEE1F025F3

P2860

Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients.

http://www.wikidata.org/entity/Q44801909

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Quantitative polymerase chain ...... in immunocompromised patients.

@en

Quantitative polymerase chain ...... in immunocompromised patients.

@nl

type

label

Quantitative polymerase chain ...... in immunocompromised patients.

@en

Quantitative polymerase chain ...... in immunocompromised patients.

@nl

prefLabel

Quantitative polymerase chain ...... in immunocompromised patients.

@en

Quantitative polymerase chain ...... in immunocompromised patients.

@nl

P1433

Q44801909-27EEB9E6-3468-4898-BCC9-68DD4A8B53E1

P1476

Q44801909-31588217-A46B-457C-98E8-1EA8F22630E9

P2093

Q44801909-0DE81D7F-8389-4571-AD24-858859C4A0DA

Q44801909-2A7D772A-9BAB-4EE7-B1B3-8960F0A93B9C

Q44801909-4BD1310B-9492-4999-B846-7BB50F014E27

Q44801909-538C736E-A4E6-4B8B-B176-5FA73B9D38FE

Q44801909-59FF7F1A-4160-4A6E-A9E6-3E8422389CF7

Q44801909-5A393554-1181-4419-B829-F41D2EA37A2F

Q44801909-B333A8D9-5D15-4F40-8CE1-5EFA6CB4EB53

Q44801909-E4E4A4F5-8349-498D-A718-4641A8C92C12

P2860

Q44801909-07045D58-4566-4A3D-B611-0714C123D3DA

Q44801909-0F274DB4-5136-43FF-A29B-DE2413F5728E

Q44801909-2483A5C8-9FD2-4D5F-8677-707F3AAC2D35

Q44801909-2A5147A2-B1D9-475F-B5E8-9EAD23F23CA7

Q44801909-3CC50072-E3A9-466D-8B81-146B1CC61462

Q44801909-3EC6D71B-CEB6-4D88-BA03-2D1B4E1CC02D

Q44801909-51CFD5C5-0BA7-4F9F-BF57-04D69F662336

Q44801909-598CDDE3-8E14-4BCE-AB01-C895A187B30A

Q44801909-66CBF5D9-4AB2-49EC-B438-06ED08B70C06

Q44801909-85965E7A-9192-4EB1-BC32-D0E1D2514F59

P304

Q44801909-AA5AF5BE-7FBE-4797-A534-E196D2D5507C

P31

Q44801909-89696087-2B37-4A8C-8DBA-A0C0732F4C84

P356

Q44801909-6227A8DF-179A-4C2C-A956-E036DBA98FCF

P407

Q44801909-E2E07306-F4A4-4F5B-AA40-7B4686D9160B

P433

Q44801909-5181F05B-F615-41E1-A70B-DD3A0D959D90

P478

Q44801909-ACA8E7D1-8229-415A-863F-A04F2524849C

P50

Q44801909-53F6155D-03F2-4956-82A0-7D4146AC1C29

Q44801909-B43077DE-2AF5-4EE2-B4F0-E051441EFE79

P577

Q44801909-26A62BE1-CD35-4563-99C0-E151D4C087DC

P5875

Q44801909-D7B6B18F-73B2-4B46-A231-EBA8699F17AE

P698

Q44801909-3F81D562-AEF9-4F68-911E-B7AA520C0850

P356

P1433

Clinical Infectious Diseases

P1476

Quantitative polymerase chain ...... in immunocompromised patients

@en

P2093

Anne-Pauline Bellanger

http://www.w3.org/2001/XMLSchema#string

Emeline Scherer

http://www.w3.org/2001/XMLSchema#string

Etienne Daguindau

http://www.w3.org/2001/XMLSchema#string

Fabrice Larosa

http://www.w3.org/2001/XMLSchema#string

Faezeh Legrand

http://www.w3.org/2001/XMLSchema#string

Joel Leroy

http://www.w3.org/2001/XMLSchema#string

Laurence Millon

http://www.w3.org/2001/XMLSchema#string

Quentin Lepiller

http://www.w3.org/2001/XMLSchema#string

P2860

Species recognition and clinical relevance of the zygomycetous genus Lichtheimia (syn. Absidia pro parte, Mycocladus)

Molecular and phenotypic evaluation of Lichtheimia corymbifera (formerly Absidia corymbifera) complex isolates associated with human mucormycosis: rehabilitation of L. ramosa

Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006.

Role of molds in farmer's lung disease in Eastern France.

Ribosomal and mitochondrial DNA target for real-time PCR diagnosis of invasive aspergillosis

Real-time PCR method for detection of zygomycetes

Molecular methods to improve diagnosis and identification of mucormycosis

PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue.

Future directions in mucormycosis research.

Increasing incidence of mucormycosis in University Hospital, Belgium.

P304

e95-101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIT094

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

Frédéric Grenouillet

P577

2013-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235659418

http://www.w3.org/2001/XMLSchema#string

P698

23420816

http://www.w3.org/2001/XMLSchema#string